Skip to main content
PBF logo

PBF — Investor Relations & Filings

Ticker · 1760 ISIN · TW0001760007 LEI · 54930078VUU2LBPR2729 TW Manufacturing
Open in API
Filings indexed 1,559 across all filing types
Latest filing 2024-05-10 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1760

About PBF

http://www.pbf.com.tw

Panion & BF Biotech Inc. is a biotechnology company focused on pharmaceutical research, development, and manufacturing. Founded in 1976, the firm operates across several core sectors, including new drug innovation, medical aesthetics, and nutritional supplements. It is recognized for its "Total Aging Management" strategy, which addresses the health needs of an aging population through a diverse product portfolio. Key offerings include treatments for chronic kidney disease, specifically phosphate binders, as well as dermatological drugs, hair care solutions, and rapid diagnostic technologies. The company integrates clinical-grade pharmaceutical standards into its consumer health and aesthetic products, serving markets in chronic disease care and preventative wellness.

Recent filings

Filing Released Lang Actions
113年第1季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data specifically about changes in equity, including items such as common stock capital, capital surplus, legal surplus reserve, special surplus reserve, undistributed earnings, retained earnings, foreign currency translation adjustments, and total equity. The data is presented for the current and previous comparable periods (first quarter of the year 113 and 112 in the Taiwanese calendar, corresponding to 2024 and 2023). The document is a financial statement showing comprehensive equity changes over a quarterly period. The length of the document is 3297 characters, which is relatively short but contains substantive financial data, not just an announcement or a certification. This matches the characteristics of an Interim / Quarterly Report (IR), which includes actual financial statements and analysis for a period shorter than a full fiscal year. Therefore, the document should be classified as an Interim / Quarterly Report (IR).
2024-05-10 Chinese
113年第1季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated cash flow statement for the first quarter of the fiscal year 2024 (民國113年第1季), with detailed financial data including operating, investing, and financing cash flows. The presence of actual financial figures for a quarterly period indicates this is a substantive financial report for a period shorter than a full fiscal year. The document length is 2263 characters, which is relatively short but contains detailed financial data, so it is not merely an announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2024-05-10 Chinese
113年第1季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated comprehensive income statement for the first quarter of the fiscal year 113 (which corresponds to 2024 in the Taiwanese calendar). It includes detailed financial data such as revenue, costs, expenses, net income, and earnings per share for the quarter ending March 31, 2024, compared to the same period in the previous year. The presence of actual financial statements and substantive financial data for a period shorter than a full fiscal year indicates this is an Interim / Quarterly Report. The document length is 2142 characters, which is sufficient to contain financial data, not just an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2024-05-10 Chinese
113年第1季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple dates including the first quarter of the year 2024 (民國113年第1季). It includes actual financial figures such as assets, liabilities, and equity, which are typical components of a financial report. The length of the document is 4023 characters, which is relatively short but contains substantive financial data rather than just an announcement or a link to a report. The presence of quarterly financial data and the date references indicate this is a quarterly or interim financial report rather than an annual report or other filing type. Therefore, the document is best classified as an Interim / Quarterly Report (IR).
2024-05-10 Chinese
公告本公司董事會通過113年第一季合併財務報告
Interim / Quarterly Report Classification · 95% confidence The document is a public announcement from a listed company (1760 寶齡富錦) reporting the board's approval of the consolidated financial report for the first quarter of the year 113 (Taiwan calendar, equivalent to 2024). It includes specific financial data for the period 113/01/01 to 113/03/31, such as revenue, gross profit, operating profit, net profit, EPS, total assets, liabilities, and equity. The document is short (905 characters) and appears to be a formal announcement of the board's approval of the quarterly financial report rather than the full report itself. It does not contain detailed financial statements or comprehensive analysis but summarizes key financial figures. Therefore, it fits the category of an Interim / Quarterly Report (IR), as it provides substantive financial data for a period shorter than a full fiscal year.
2024-05-10 Chinese
113年4月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a company named 寶齡富錦, providing data on fund lending balances and endorsement guarantees for the current and previous month, with no complex financial statements or detailed analysis. The length is very short (613 characters), and it mainly reports current financial status without any narrative or comprehensive financial report content. It does not contain an annual or interim report, audit report, or earnings release. It is a regulatory disclosure of financial data, likely a routine regulatory filing. Therefore, it fits best under Regulatory Filings (RNS).
2024-05-09 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.